Skip to Main Content

Author Details

Donggeon Kim
Institute for Refractory Cancer Research, Samsung Medical Center
2009
28
13
PMIDPaper TitleJournal TitlePublished Year
36915208Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma.Genome Med2023
37788099The semaphorin 3A/neuropilin-1 pathway promotes clonogenic growth of glioblastoma via activation of TGF-β signaling.JCI Insight2023
33828082Mutation-specific non-canonical pathway of PTEN as a distinct therapeutic target for glioblastoma.Cell Death Dis2021
32120790Sphere-Forming Culture for Expanding Genetically Distinct Patient-Derived Glioma Stem Cells by Cellular Growth Rate Screening.Cancers (Basel)2020
33142709Therapeutic Efficacy of GC1118, a Novel Anti-EGFR Antibody, against Glioblastoma with High EGFR Amplification in Patient-Derived Xenografts.Cancers (Basel)2020
33073104cIRCR201-dPBD, a Novel Pyrrolobenzodiazepine Dimer-Containing Site-Specific Antibody-Drug Conjugate Targeting c-Met Overexpression Tumors.ACS Omega2020
33149237Correction: Secretome analysis of patient-derived GBM tumorspheres identifies midkine as a potent therapeutic target.Exp Mol Med2020
32847614Transcriptional regulatory networks of tumor-associated macrophages that drive malignancy in mesenchymal glioblastoma.Genome Biol2020
30898893PIP4K2A as a negative regulator of PI3K in PTEN-deficient glioblastoma.J Exp Med2019
31811117Secretome analysis of patient-derived GBM tumor spheres identifies midkine as a potent therapeutic target.Exp Mol Med2019
31771279Promising Therapeutic Efficacy of GC1118, an Anti-EGFR Antibody, against KRAS Mutation-Driven Colorectal Cancer Patient-Derived Xenografts.Int J Mol Sci2019
29939324Identification of genomic and molecular traits that present therapeutic vulnerability to HGF-targeted therapy in glioblastoma.Neuro Oncol2019
30085274Distinct genomic profile and specific targeted drug responses in adult cerebellar glioblastoma.Neuro Oncol2019
31370279Novel Semi-Replicative Retroviral Vector Mediated Double Suicide Gene Transfer Enhances Antitumor Effects in Patient-Derived Glioblastoma Models.Cancers (Basel)2019
29535421Astrocyte-derived CCL20 reinforces HIF-1-mediated hypoxic responses in glioblastoma by stimulating the CCR6-NF-κB signaling pathway.Oncogene2018
30262818Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy.Nat Genet2018
29715102Pharmacokinetics, Biodistribution, and Toxicity Evaluation of Anti-SEMA3A (F11) in <i>In Vivo</i> Models.Anticancer Res2018
28917835Antitumor activity, pharmacokinetics, tumor-homing effect, and hepatotoxicity of a species cross-reactive c-Met antibody.Biochem Biophys Res Commun2017
28902178Tumor Inhibitory Effect of IRCR201, a Novel Cross-Reactive c-Met Antibody Targeting the PSI Domain.Int J Mol Sci2017
27102443Anti-miR delivery strategies to bypass the blood-brain barrier in glioblastoma therapy.Oncotarget2016
26586721GC1118, an Anti-EGFR Antibody with a Distinct Binding Epitope and Superior Inhibitory Activity against High-Affinity EGFR Ligands.Mol Cancer Ther2016
26578300Facilitating tailored therapeutic strategies for glioblastoma through an orthotopic patient-derived xenograft platform.Histol Histopathol2016
26444992FoxM1 Promotes Stemness and Radio-Resistance of Glioblastoma by Regulating the Master Stem Cell Regulator Sox2.PLoS One2015
26325365Anticancer activity of TTAC-0001, a fully human anti-vascular endothelial growth factor receptor 2 (VEGFR-2/KDR) monoclonal antibody, is associated with inhibition of tumor angiogenesis.MAbs2015
24675832Effects of resveratrol on the insulin signaling pathway of obese mice.J Vet Sci2014
21945106Resveratrol improves insulin signaling in a tissue-specific manner under insulin-resistant conditions only: in vitro and in vivo experiments in rodents.Metabolism2012
23107740Nitric oxide-mediated vasorelaxation effects of anti-angiotensin I-converting enzyme (ACE) peptide from Styela clava flesh tissue and its anti-hypertensive effect in spontaneously hypertensive rats.Food Chem2012
19700032Uncooked rice of relatively low gelatinization degree resulted in lower metabolic glucose and insulin responses compared with cooked rice in female college students.Nutr Res2009
  • 1 - 28 of 28

Recommended Authors

Zhuhai People's Hospital (Zhuhai Hospital Affiliated with Jinan University)
Career Start Year 2013
Number of shared co-authors 0
Georgia Cancer Center, Augusta University
Career Start Year 2011
Number of shared co-authors 0
Roswell Park Comprehensive Cancer Center
Career Start Year 2010
Number of shared co-authors 0
Westlake University
Career Start Year 2009
Number of shared co-authors 0
California Pacific Medical Center Research Institute
Career Start Year 2009
Number of shared co-authors 0
Goldfinch Bio Inc.
Career Start Year 2007
Number of shared co-authors 0
Ontario Institute for Cancer Research, University Avenue
Career Start Year 2007
Number of shared co-authors 0
Guangdong General Hospital, Guangdong Academy of Medical Sciences
Career Start Year 2007
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 2006
Number of shared co-authors 0
University of Alabama at Birmingham
Career Start Year 2005
Number of shared co-authors 0
The MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 4
University of Alabama at Birmingham
Career Start Year 2005
Number of shared co-authors 0
University of Alabama at Birmingham
Career Start Year 2004
Number of shared co-authors 1
Northwestern University Feinberg School of Medicine
Career Start Year 2003
Number of shared co-authors 1
The Institute of Biomedical Sciences, East China Normal University
Career Start Year 2002
Number of shared co-authors 0
Steadman Philippon Research Institute, Center for Regenerative Sports Medicine
Career Start Year 2001
Number of shared co-authors 0
West China Second Hospital, Sichuan University
Career Start Year 2000
Number of shared co-authors 0
University of Alabama at Birmingham
Career Start Year 2000
Number of shared co-authors 0
Royal College of Surgeons in Ireland (RCSI)
Career Start Year 1999
Number of shared co-authors 0
Livestrong Cancer Institutes, Dell Medical School, The University of Texas at Austin
Career Start Year 1997
Number of shared co-authors 0
University of Illinois at Urbana-Champaign
Career Start Year 1996
Number of shared co-authors 3
Northwestern University Feinberg School of Medicine
Career Start Year 1996
Number of shared co-authors 5
Clinical Medical Research Center of Hepatic Surgery at Hubei Province
Career Start Year 1995
Number of shared co-authors 4
Stanford University
Career Start Year 1994
Number of shared co-authors 1
UPMC Hillman Cancer Center, University of Pittsburgh Medical Center
Career Start Year 1992
Number of shared co-authors 9
Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania
Career Start Year 1991
Number of shared co-authors 0
Meyer Cancer Center
Career Start Year 1990
Number of shared co-authors 8
Telethon Kids Institute
Career Start Year 1990
Number of shared co-authors 1
The Netherlands Cancer Institute
Career Start Year 1989
Number of shared co-authors 0
University of Colorado School of Medicine
Career Start Year 1974
Number of shared co-authors 0

Collaborators

Samsung Medical Center, Sungkyunkwan University School
Co-authored papers 22
Korea University, College of Medicine
Co-authored papers 12
Gangnam Severance Hospital
Co-authored papers 8
Yonsei University College of Medicine, Severance Hospital
Co-authored papers 8
Touro College of Osteopathic Medicine
Co-authored papers 8
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 8
Lerner Research Institute, Cleveland Clinic
Co-authored papers 7
Research Institute for Future Medicine, Samsung Medical Center
Co-authored papers 7
Sungkyunkwan University
Co-authored papers 7
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 7
Seoul National University, College of Medicine
Co-authored papers 7
Institute for Refractory Cancer Research, Samsung Medical Center
Co-authored papers 6
Cancer Stem Cell Research Center, Samsung Biomedical Research Institute
Co-authored papers 6
Korea University College of Medicine
Co-authored papers 6
Institute for Refractory Cancer Research, Samsung Medical Center
Co-authored papers 5
Genomic Medicine Institute, Medical Research Center, Seoul National University
Co-authored papers 5
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 4
Columbia University Vagelos College of Physicians and Surgeons
Co-authored papers 4
Kyungpook National University
Co-authored papers 4
Samsung Genome Institute, Samsung Medical Center
Co-authored papers 4
Sungkyunkwan University
Co-authored papers 4
Samsung Medical Center, Sungkyunkwan University
Co-authored papers 4
Cancer Stem Cell Research Center, Samsung Biomedical Research Institute
Co-authored papers 3
University of Chinese Academy of Sciences
Co-authored papers 3
Columbia University
Co-authored papers 2
College of Medicine, Seoul National University
Co-authored papers 2
Luxembourg Institute of Health
Co-authored papers 2
Yale School of Medicine
Co-authored papers 2
Inha University
Co-authored papers 2
Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami
Co-authored papers 2